GLP1R and type 2 diabetes mellitus: In this context, many studies have been held to identify possible defects in the incretin secretion among deterioration of glucose tolerance, but no substantial differences in the GIP and GLP-1 secretion in response to an oral glucose tolerance test (OGTT) or mixed meal test (MMT) have been identified in T2D patients compared to healthy people (7, 8).